Psychiatric services in primary care settings: a survey of general practitioners in Thailand by Lotrakul, Manote & Saipanish, Ratana
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
Psychiatric services in primary care settings: a survey of general 
practitioners in Thailand
Manote Lotrakul* and Ratana Saipanish
Address: Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand
Email: Manote Lotrakul* - ramlt@mahidol.ac.th; Ratana Saipanish - rarsp@mahidol.ac.th
* Corresponding author    
Abstract
Background: General Practitioners (GPs) in Thailand play an important role in treating psychiatric
disorders since there is a shortage of psychiatrists in the country. Our aim was to examine GP's
perception of psychiatric problems, drug treatment and service problems encountered in primary
care settings.
Methods: We distributed 1,193 postal questionnaires inquiring about psychiatric practices and
service problems to doctors in primary care settings throughout Thailand.
Results: Four hundred and thirty-four questionnaires (36.4%) were returned. Sixty-seven of the
respondents (15.4%) who had taken further special training in various fields were excluded from
the analysis, giving a total of 367 GPs in this study. Fifty-six per cent of respondents were males and
they had worked for 4.6 years on average (median = 3 years). 65.6% (SD = 19.3) of the total
patients examined had physical problems, 10.7% (SD = 7.9) had psychiatric problems and 23.9% (SD
= 16.0) had both problems. The most common psychiatric diagnoses were anxiety disorders
(37.5%), alcohol and drugs abuse (28.1%), and depressive disorders (29.2%). Commonly prescribed
psychotropic drugs were anxiolytics and antidepressants. The psychotropic drugs most frequently
prescribed were diazepam among anti-anxiety drugs, amitriptyline among antidepressant drugs, and
haloperidol among antipsychotic drugs.
Conclusion: Most drugs available through primary care were the same as what existed 3 decades
ago. There should be adequate supply of new and appropriate psychotropic drugs in primary care.
Case-finding instruments for common mental disorders might be helpful for GPs whose quality of
practice was limited by large numbers of patients. However, the service delivery system should be
modified in order to maintain successful care for a large number of psychiatric patients.
Background
Studies show a serious shortage of mental health profes-
sionals, particularly of psychiatrists [1-3] in developing
countries. Thailand is one such country. It is a lower mid-
dle-income country with a population of 62.3 million in
2002, 65% of whom reside in rural areas. In 2000, there
were 180,252 practicing medical doctors in Thailand [4].
In 2004, there were only seven psychiatrists per million
inhabitants and 55% of them were concentrated in Bang-
kok [5]. There are no psychiatrists available in a number
of provincial general hospitals. General practitioners
(GPs) therefore play a crucial role in the detection and
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treatment of mental illnesses. Recently there was a radical
shift in the health financing system in Thailand that
placed even more emphasis on the importance of GPs in
mental health care.
Since the Thai government embarked on a program to
provide universal health-care coverage in 2001, dramatic
changes have occurred in the health care provision in
Thailand [6]. The system covers all previously uninsured
people and those from the lowest income groups – more
than 30% of the population. Under this new scheme, peo-
ple buy a card that entitles the holder to medical care and
treatment for a fee of 30 baht (0.70 USD) per ambulatory
visit or hospitalization [7]. This covers most care except
some high cost interventions such as kidney dialysis and
antiretroviral therapy. Funding is through a capitation
from the government's tax revenue to health care facilities
according to the number of local residents registered with
each facility. Primary Care Units (PCUs: health centres
and units set up in hospitals to provide primary care) have
been established to provide basic or primary care to the
people within the vicinity of their residence, with a link-
age in a holistic manner as well as referral system to higher
levels of health care facilities. A typical province will have
five to seven district primary care networks, each led by a
contractor unit with one or two networks in the provincial
city [8]. In rural or semi-rural areas, a patient's first contact
with medical services is usually at the primary care unit.
No appointments are necessary for consultation. A typical
visit lasts about 3–5 minutes. Patients are allowed to
access specialist care only after approval from their GP
who is responsible for the referral. People may bypass pri-
mary care to a tertiary provincial general hospital but then
they have to pay the cost themselves. Consequently,
patients with psychiatric disorders usually choose to see
GPs in their assigned PCU instead of going directly to a
mental hospital or to the psychiatric department of the
provincial general hospital.
Psychopharmacologic treatments for psychiatric disorders
have advanced greatly in recent years. There are various
new effective drugs with fewer side effects. It is therefore
necessary for GPs to gain more knowledge and skills in
diagnosing and treating common mental disorders in
order to maintain the standard of care for psychiatric
patients that will be more prevalent in primary care during
this health reform period.
The purpose of this study was to investigate the prevalence
of psychiatric disorders from GPs' perspectives, the drugs
used, as well as the problems and barriers in providing
psychiatric services in Thailand.
Methods
This study was carried out by cross-sectional postal ques-
tionnaire survey. Ethical approval for the project was
obtained from Ethical Clearance Committee on Human
Rights Related to Research Involving Human Subjects, at
the Faculty of Medicine, Ramathibodi Hospital, Mahidol
University. A list of current community hospitals was
obtained from the Bureau of Health Service System Devel-
opment, Ministry of Public Health. During August-Sep-
tember 2004, we sent questionnaires to hospitals on the
list, which consisted of 143 hospitals with only one doc-
tor and 525 hospitals with several doctors. To avoid a clus-
tering problem in the data from hospitals of the latter
group, we sent only 2 copies of the questionnaire to each
hospital. A total of 1,193 copies of the questionnaire were
sent.
Instrument
The postal questionnaire for the study consisted of 5 parts:
i) The GP's demographic and practice characteristics
ii) GPs were asked to rate the prevalence of 3 groups of
patients; patients with physical problems, patients with
psychiatric problems and patients with both problems.
iii) Prevalence of common psychiatric diagnostic groups.
We have provided a brief description for each diagnostic
group according to DSM-IV. We used DSM rather than the
ICD-10 Primary Care Version, which would seem to be a
more appropriate classification for GPs [9] because psy-
chiatry teaching in the undergraduate medical curricula in
Thailand is based on the DSM system as most of the senior
faculty were trained from the United States. Conse-
quently, GPs in Thailand are not familiar with the ICD-10
psychiatric classification system.
iv) GPs were asked to estimate the prevalence of each diag-
nostic group by using a visual analog scale (VAS). The vis-
ual analog scale consists of a ten point straight line with
"0" at the left end and "100" at the right end indicating the
percentage of each psychiatric diagnosis of total patients
examined. GP's confidence in recognizing each psychiat-
ric disorder was assessed by using a Likert-type scale with
five options, on which "1" indicates least confident and
"5" indicates most confident.
v) GPs were asked to rate the extent that each barrier has
affected the diagnosis of psychiatric problems by using a
Likert-type scale ranging from 1 (strongly disagree) to 5
(strongly agree).
vi) GPs were asked to rate the percentage of each psycho-
tropic drug group prescribed and to name common drugs
prescribed in each group.BMC Family Practice 2006, 7:48 http://www.biomedcentral.com/1471-2296/7/48
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Data analysis
Statistical analyses were performed using the SPSS statisti-
cal package. Frequency distribution, cross-tabulation and
chi-square tests were used to analyze categorical data.
Continuous data were analyzed using student's t-tests and
analyses of variance (ANOVAs). The Pearson product-
moment correlation was used to establish the relation-
ships between the variables. The significance level was set
at P < 0.05.
Results
Sample characteristics
444 questionnaires were returned. Ten incomplete ques-
tionnaires were excluded. A total of 434 questionnaires
were analyzable, giving a response rate of 36.4%. Sixty-
seven of the respondents (15.4%) had taken further spe-
cial training in various fields such as medicine, surgery
and orthopedics. We excluded these from our analysis
because their training might affect their perception and
practice. As such, a total of 367 GPs were included in this
study. Among these respondents, 56.4% were males and
they had worked for 4.6 years on average (median = 3
years). The distribution of respondents by graduate medi-
cal schools was in line with that of the country. They prac-
ticed in all 5 regions of the country: Central (9.9%), East
(9.02%), Northeast (35.5%), North (26.5%) and South
(19.2%). Seventy-two per cent of GPs examined more
than 50 patients per day and 40% of them saw more than
70 patients per day (Figure 1).
GP's opinions on patients with psychiatric problems
GPs stated that 65.6% (SD = 19.3, median = 70) of their
total number of patients examined had only physical
problems, while 10.7% (SD = 7.9, median = 10) had only
psychiatric problems and 23.9% (SD = 16.0, median =
20) had both physical and psychiatric problems.
Results of a one-way ANOVA showed a significant differ-
ence between the number of patients examined per day
(<20, 21–30, 31–40, to >70) and the mean percentage of
patients with psychiatric problems (F = 2.69; df = 6, 331;
p < 0.015). A post-hoc Tukey test revealed a significant dif-
ference between GPs who examined 31–40 patients/day
and those who examined 60–70 patients/day. There were
no significant differences in the mean percentage of
patients with physical problems and patients with both
physical and psychiatric problems among each range of
patients examined per day.
Barriers to diagnosis of psychiatric disorders
Common barriers to diagnosis of psychiatric disorders
were time constraints, lack of experience in psychiatric
patient care and limited psychiatric knowledge (Table 1).
For time constraints, the number of GPs who answered
"agree" and "strongly agree" was as high as 76.2%.
A Pearson product-moment correlation was used to
explore the association between each barrier problem and
the perception of psychiatric prevalence. We found that
the perceived psychiatric prevalence was significantly
associated with only three variables. It had a negative cor-
relation with the lack of interviewing skills (r = -0.136, P
= 0.013) and the lack of experience in psychiatric patient
care (r = -0.108, P = 0.048). However, it correlated posi-
tively with the problem of time constraints (r = 0.143, P =
0.009).
Frequency of each psychiatric diagnosis
Table 2 shows frequently found diagnostic groups. These
were anxiety disorders, alcohol and drug use disorders,
and depressive disorders, respectively. GPs were more
confident in assessing frequently found psychiatric diag-
nostic groups.
Drug treatment
The most frequently used psychotropic drugs among GPs
were anxiolytics, followed by antidepressants and antipsy-
chotics, respectively. Frequently used drugs in each drug
group were diazepam, amitriptyline and haloperidol,
respectively (Table 3).
Discussion
According to Thai government regulations, newly gradu-
ated doctors have to start working up-country for 1–3
years before they can pursue further medical specialty
training [10]. These physicians make up a substantial por-
tion of the GPs in the country. Most of them worked in the
Northeast, followed by the North which was close to the
distribution proportion of GPs [4]. Overall, respondents'
Percentage of GPs by consultation rates Figure 1
Percentage of GPs by consultation rates.
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characteristics reflected the nature of GPs working in com-
munity hospitals.
Prevalence of mental disorder in primary care in develop-
ing countries varies from 9.8% in China [11], to 17–46%
in India [11,12], 21.3% in Nigeria [13], 38.2% in Taiwan
[14], 47–56% in Brazil [15] and 53.5% in Chile [11]. Thai
GPs in this study perceived that about 10% of their
patients had psychiatric problems, which was low com-
pared to other studies. A major basis of this difference is
that most of mentioned studies performed a direct assess-
ment of the patients by using various instruments whereas
our study was an opinion survey. Considering that there is
a tendency of GPs to underestimate the prevalence of psy-
chiatric morbidity among their patients [11,15], the actual
prevalence of psychiatric disorders should be higher than
what was found.
Our study revealed that GPs who faced with more time
constraints tended to perceive that there were more psy-
chiatric patients in their practice. It seems to contradict the
commonly held view that the larger the number of
patients examined, the more psychiatric problems go
undetected and undertreated [16]. This is due to the fact
that our study was an opinion survey. The answers of
many respondents may be based on their attitude and
concern but not their practice. Our findings may reflect
that these GPs were concerned that there were a number
of psychiatric patients in their routine care but they had
difficulty in arriving at a definitive diagnosis due to time
constraints. We are cautious in providing justification for
this finding as the correlation between these two variables
(the problem of time constraints and the perception of
psychiatric problems) was very weak. A further study
should be conducted to find whether their 'real world'
practice shows the same tendency.
Our study showed that a number of patients with alcohol
and drug abuse visited GPs. However, the questionnaire
did not ask in detail about patients' alcohol related prob-
lems. In the international study of mental illness in pri-
mary care it was also found that alcoholic use disorders
were a major problem in primary care of many countries
[11]. A recent epidemiological study of psychiatric disor-
ders in Thailand revealed that the prevalence of alcohol
use disorders among community samples was as high as
28.5%, whereas the prevalence of major depressive disor-
der and generalized anxiety disorder were only 2.30% and
1.27%, respectively [17].
Our GPs perceived that their patients were more likely to
have anxiety disorders than depressive disorders (37.5%
vs. 29.2%) whereas studies from other countries showed
that depressive disorders were much more common [11-
13,15,18].
The reason that GPs perceived that there were not many
patients with depressive disorders could come from that
fact that GPs had less awareness of depressive disorders
than anxiety disorders. A previous study of patients
attending 4 sites of primary care setting in the central part
of Thailand of Silpakit [19] showed that mixed anxiety
Table 1: Barriers to diagnosis of psychiatric disorders
Ranking of barriers to diagnosis (1–5, mean, SD)
Time constraints 4.1 (0.9)
Lack of experience in psychiatric patient care 3.7 (0.9)
Limited psychiatric knowledge 3.4 (0.8)
Lack of interviewing skill 3.4 (0.9)
Lack of interest in psychiatric services 3.1 (1.0)
Table 2: Common psychiatric diagnostic categories and recognition confidence
Per cent (SD) Ranking of recognition confidence (1–5, mean, 
SD)
Anxiety disorders 37.5 (21.8) 3.5 (0.9)
Alcohol and drug use disorders 28.1 (19.6) 3.4 (0.8)
Depressive disorders 29.2 (20.0) 3.4 (0.8)
Psychotic disorders 23.9 (19.0) 3.3 (0.9)
Unspecified psychiatric disorders 21.0 (17.8) 2.4 (0.9)
Somatoform disorders 18.2 (16.8) 2.7 (1.0)
Organic mental syndrome 18.3 (15.5) 2.8 (0.8
Bipolar disorders 8.9 (8.2) 2.5 (1.1)
Child psychiatric problems 8.2 (9.7) 2.3 (1.1)BMC Family Practice 2006, 7:48 http://www.biomedcentral.com/1471-2296/7/48
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and depressive disorder was much more common than
depressive disorder. We did not have an item asking about
mixed anxiety and depressive disorder in our study
because it is a term in ICD-10 diagnostic categories that is
unfamiliar to GPs. It is possible that GPs combined mixed
anxiety and depressive disorder, which is less severe than
major depressive disorder, with the anxiety disorder
group.
Confidence in recognizing a disease was related to the fre-
quency of disease found. However, this did not show that
GPs' treatments were effective. For examples, GPs' confi-
dence in treating depressive disorders was ranked high,
but we found that their most frequently prescribed antide-
pressant was amitriptyline (94.5%) which has many
adverse effects. A study conducted by Saipanish et al. 7
years ago [20], showed that, among antidepressants pre-
scribed, 96.7% of GPs used amitriptyline. Therefore, it
was only a slight decrease in amitriptyline use despite the
fact that selective serotonin reuptake inhibitor (SSRI) anti-
depressants have been available in Thailand for more than
a decade.
Current psychotropic drugs available in Thailand are not
very different from those in many developed countries.
Examples of these medicines are venlafaxine, mirtazapine,
and escitalopram among antidepressant drugs; and olan-
zapine, ziprasidone, quetiapine, and aripiprazone among
atypical antipsychotic drugs. However, these medicines
are available only in university hospitals, mental hospi-
tals, and large regional hospitals and they are not listed in
the National Essential Drug List (NEDL). According to the
government regulations, most medicines available at pri-
mary care are those listed in the NEDL. For medicines not
listed in NEDL, patients have to pay out-of-pocket unless
their physicians approve that the medicines as necessary
and appropriate. For antidepressant drugs other than tri-
cyclic antidepressants, mianserin and fluoxetine are the
only SSRI included in the essential drug list. However,
unfortunately, they are classified as secondary essential
drugs that are not required to be available in every pri-
mary unit unless GPs requested for them. In most primary
care units, only amitriptyline among antidepressant drugs
and haloperidol among antipsychotic drugs are available
whereas a few anti-anxiety medications such as diazepam,
lorazepam and chlorazepate can be obtained.
Tricyclic antidepressants in primary care are frequently
used in low doses that are unlikely to be of benefit in treat-
ing depression, generally because of their intolerable side
effects [21,22]. Although there are arguments that low
dosage tricyclic antidepressants are effective for depres-
sion, the low dose mentioned with these arguments is
between 75–100 mg/day [23,24] whereas most GPs' in
Thailand prescribed doses is between 25–50 mg/day.
Fluoxetine is a selective serotonin reuptake inhibitor
(SSRI) antidepressant that has better tolerability and is
easier to administer than tricyclic antidepressants [25,26].
Recent studies have shown that besides depressive disor-
ders, SSRIs can also alleviate anxiety symptoms and treat
some anxiety disorders such as panic disorder, social pho-
bia and obsessive-compulsive disorder [27-29]. A generic
form of SSRI such as fluoxetine is recommended as first
line drug for the treatment of depressive disorders by the
guideline from the National Institute for Clinical Excel-
lence (NICE) [30] from England because it is as effective
as tricyclic antidepressants and its use is less likely to be
discontinued because of side-effects. It is also generally
associated with fewer discontinuation symptoms.
Recently, a study from Asian country has shown that
fluoxetine can be used to treat patients with anxiety and/
or depression safely and cost-effectively in primary care
settings of low-income countries [31]. These advantages
are reinforced by the fact that fluoxetine has been availa-
ble in Thailand for more than a decade and there is now a
generic version of fluoxetine available within the country
at a very low price (0.05 USD per capsule). Attempts
should be made to encourage GPs in our country to adopt
fluoxetine as the first-line treatment for depressive disor-
ders.
Anxiolytics were most frequently used among GPs in our
study (40.6%). The high prevalence of benzodiazepines
in primary care is common in most countries, especially
the developing countries such as China (33%), India
(32%) and Chile (48%) [11]. A previous study from Thai-
land found that, apart from psychiatric treatment, GPs
also prescribed benzodiazepines for non-psychiatric con-
ditions such as essential hypertension and uncomplicated
lower back pain [32]. The most frequently prescribed anx-
iolytics in our study was diazepam, followed by
lorazepam and chlorazepate. All of them are listed in the
Table 3: Commonly prescribed psychotropic drugs by GPs
% of total patients 
prescribed (SD)
Three most frequently prescribed drugs (percentage of each drug group)
Anxiolytics 40.6 (20.5) diazepam (76.7) chlorazepate (10.3) lorazepam (9.4)
Antidepressants 30.2 (19.8) amitriptyline (94.5) fluoxetine (4.0) nortriptyline (1.5)
Antipsychotics 22.7 (17.7) haloperidol (88.5) chlorpromazine (9.4) perphenazine (1.8)BMC Family Practice 2006, 7:48 http://www.biomedcentral.com/1471-2296/7/48
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National Essential Drug List. A study by Srisurapanont et
al. [32] showed that 45.5% of GPs stated that part of the
reasons for their excessive use of benzodiazepines was the
lack of time as well as the lack of knowledge and skills.
This is in line with a study from Brazil which showed that
GPs have a tendency to use benzodiazepines due to diffi-
culties in making differential diagnosis [11].
Our study showed that psychiatric drug prescribing
behavior by Thai GPs has largely been governed by
administrative factors rather than academic progress. Evi-
dence from developing countries suggests that common
strategies such as disseminating treatment guidelines and
providing training programs for GPs are only successful
when they are accompanied by a strategy to increase the
ease of accessibility to new and appropriate psychiatric
drugs [11,33,34].
The perception of psychiatric prevalence among GPs in
our study was low and the conditions of heavy workload
left them with little time to provide a thorough assess-
ment for psychiatric problems. Thus case-finding instru-
ments for common mental disorders might play an
essential role in assisting GPs in identify mental disorders
in their patients. During the last few years, various screen-
ing instruments in Thai language have been developed to
detect depression, anxiety and mental health conditions,
such as the General Health Questionnaire (GHQ) [35],
the Health-related self-report (HRSR) scale [36], the Thai
Depression Inventory (TDI) [37], the Center for Epidemi-
ological Studies Depression Scale (CES-D) [38] and the
Hospital Anxiety and Depression Scale (HADS) [39].
However, new psychiatric cases found from such instru-
ments may just be the add-on burden to GPs whose work-
load has been heavy and who are poorly equipped to
manage the spectrum of disorders that presents to them.
Fiscal and institutional constraints in health care services
should be taken into account before adopting such service
delivery programs in order to maintain successful care
[40]. In this regard, lessons form developing countries
might provide appropriate models. For instance, recently
there was a report from Chile on the success of a program
using multi-component intervention led by a non-medi-
cal health worker and included group psycho-education
about depression, systematic monitoring of symptoms
and a structured drug program for those with more severe
depression [41]. In a region where there is a shortage of
GPs, a structured approach that facilitates an increased
role for non-medical staff, patients and family members
may be more appropriate [42].
Certain limitations to this study should be recognized.
Data from these questionnaires cannot reflect the nature
of all GPs in community hospitals because a portion of
GPs in community hospitals did not send back the ques-
tionnaires. These non-responding GPs might have been
GPs who had only little interest in psychiatry or did not
perceive it as a problem. However, because this study was
a postal survey and the receiver could choose not to
respond, we were unable to acquire further information
from this group.
Another limitation is that, since our study was an opinion
survey, it may not accurately indicate what doctors do in
their 'real world' practice. The estimated percentage of
each psychiatric disorder reflected what GPs perceived
and practiced. However, some psychiatric disorders may
have been under-detected or over-emphasized, especially
anxiety disorders, depressive disorders, and somatoform
disorders. Further study on the prevalence of psychiatric
disorders in primary care settings and patients' chief pres-
entations should be conducted to reveal a broader picture
of psychiatric disorders in primary care in Thailand.
Conclusion
Frequently found problems in primary care in our study
were anxiety disorders, alcohol and drug abuse and
depressive disorders. Most drugs available in primary care
were the same as what existed 3 decades ago. The prescrib-
ing of benzodiazepines was common. Amitriptyline was a
frequently used antidepressant although generic fluoxet-
ine has been available for almost a decade. GPs' quality of
practice was also limited by the large number of patients.
Case-finding instruments for common mental disorders
might help GPs in detecting common mental disorders in
their patients. However, the service delivery system
should be adjusted in order to maintain successful care for
a large number of psychiatric patients
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